Kainos Medicine (XKRX:284620) ROE % Adjusted to Book Value : -8.92% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine ROE % Adjusted to Book Value?

Kainos Medicine's ROE % for the quarter that ended in Mar. 2024 was -95.44%. Kainos Medicine's PB Ratio for the quarter that ended in Mar. 2024 was 10.70. Kainos Medicine's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -8.92%.

Kainos Medicine ROE % Adjusted to Book Value Historical Data

The historical data trend for Kainos Medicine's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine ROE % Adjusted to Book Value Chart

Kainos Medicine Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-47.26

-3.46

-5.73

-18.98

-7.84

Kainos Medicine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-6.78	-13.67	-13.59	-8.87	-8.92

Competitive Comparison of Kainos Medicine's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Kainos Medicine's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kainos Medicine's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kainos Medicine's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Kainos Medicine's ROE % Adjusted to Book Value falls into.

Kainos Medicine ROE % Adjusted to Book Value Calculation

Kainos Medicine's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-80.48%	/	10.26
	=	-7.84%

Kainos Medicine's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-95.44%	/	10.70
	=	-8.92%

Kainos Medicine ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Kainos Medicine's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Kainos Medicine (XKRX:284620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

http://www.kainosmedicine.com

Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine (XKRX:284620) Headlines

No Headlines